|
Welcome
!
You
are not logged in.
|
|
|
|
|
| Register Contract Research Organizations |
|
| Contract Research Requests |
|
| Contract Research Careers |
|
| Contract Research News |
|
| Contract Research Training Courses and Conferences |
|
|
Need to find FDA, GMP, ICH, GLP, NON-GLP, GCP, CLIA, UKAS, AAALAC, A2LA, DEA, or ISO contract laboratories for non-clinical, preclinical, toxicology, toxicity, product safety, analytical chemistry, microbiology, virology, clinical, immunology, oncology, neurology, nutritional, physical, biomedical, bioengineering, genomics, nanotechnology, food science, toxicogenetics, proteomics, preclinical, bioanalytical, genetics, immunology, biochemistry, sterility, biophysical, efficacy, antigenecity, bioassay, pharmacokinetics, pK, pK/PD, biomarker, pharmacogenomics, medical, biomaterials, advanced materials, testing, assays, arrays, or other research and development of your pharmaceuticals, medical devices, in-vitro diagnostics, biopharmaceuticals, biologicals, food, beverages, consumer products, cosmetics, nutraceuticals, nutritional products, animal drugs or dietary supplements to validated methods, directives, or standards such as FDA, USP, BP, IVDD, CLIA, BAM, AATCC, NCCLS, ISO, ASTM, AAMI, NF, AOAC, ICH, IP, JP ?
Find Laboratories and Contract Research Organizations !
Contract Laboratory .com
Contract Laboratory .com helps you fulfill all your bioresearch, research, experiments, developments, analysis, assays, validation, in-process, stability, quality control, and finished product testing such as pharmaceuticals testing, biopharmaceuticals testing , in-vitro diagnostics testing, medical devices testing, biotechnology testing, clinical testing, blood testing, medical testing, cosmetics testing, biologics testing, food testing, cosmetics testing, pet food testing and animal drugs testing .
|
|
Contact Contract CRO .com
|
|
|
|
Contract Research News
|
|
|
| Press Release
2009-12-25 00:00:00.0
WASHINGTON, D.C. (Friday, December 25, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on today's vote by the Senate to pass "The Patient Protection and Affordable Care Act of 2009":
"The health care reform bill passed today by the Senate includes many provisions which serve as early Christmas presents for patients living with debilitating diseases such as cancer, Multiple Sclerosis, HIV/AIDS and a host of rare diseases. These provisions are a triumph for sick patients and their families. They are important steps toward realizing the critical broad goals of health care reform, namely reducing costs, expanding access and promoting continued medical breakthroughs that lea( read more)..... |
|
| Press Release
2009-10-12 00:00:00.0
Research Triangle Park, NC and Tampa, FL (21 September 2009) - Magellan BioScience Group, Inc.
(Magellan), a pioneer in innovative drug development from marine sources, and Zen-Bio, Inc. (Zen-Bio)
announced today that they will begin a multidisciplinary drug discovery collaboration to identify novel marine
microbial compounds that have potential as tools for biological research and ultimately the discovery of new
medicines.
This collaboration will bring together Magellan's unique collection of marine-derived microorganisms and their
natural product chemistry expertise with Zen-Bio's high throughput small molecule screening technologies for
human metabolic diseases. The Zen-Bio-Magellan team will utilize Zen-Bio's screening system to ( read more)..... |
|
| Press Release
2009-05-26 00:00:00.0
Oak Park, IL, May 18, 2009 - PreLabs, LLC, a Chicago-based contract research organization, is pleased to announce the addition of Stuart Knight as the Global Director of Business Development. In the newly created position, Stuart will lead the company's business development opportunities by expanding and developing strategic client relationships. His industry experience positions him to understand client requirements and effectively collaborate with the global pharmaceutical, biotechnology and medical device industries.
Stuart has over 20 years of successful international sales and marketing experience including several years with the Yamazaki Group, where he developed and integrated a significant international licensing and product( read more)..... |
|
| Press Release
2009-04-08 00:00:00.0
Oak Park, IL, October 1, 2008 - Biologic Safety Research Inc. (BSR) announced today it is joining PreLabs, LLC to expand its operations. The existing BSR management team will integrate into the PreLabs organization and continue to actively guide the future of the expanded contract laboratory. Additionally, PreLabs has appointed Boris Predovich to serve as President/CEO and Philippe Baneux DVM as Chief Scientific Officer for the newly expanded company.
Biologic Safety Research has been providing toxicology and preclinical services since 1988. "Market demand has created an exciting opportunity for us to expand our business." said Robert Locke, BSR President. "Transitioning BSR into PreLabs will leverage our existing scientific and operatio( read more)..... |
|
| Press Release
2009-03-19 00:00:00.0
GeneuityT Clinical Research Services is exhibiting at the 18th Annual Partnerships with CROs Conference in Orlando, Florida April 28-30, 2009.
This meeting will explore the best methods of forming, managing and sustaining clinical research outsourcing partnerships. We invite you to visit Booth No. 640 to learn more about services available through Geneuity. While you're visiting us there, be sure to register to win an iPod Shuffle.
For more information about this conference and Geneuity's participation and services to be featured, contact Ranee Taylor, PhD, director of business development, at 866-895-1810 or visit geneuity.com.
Geneuity provides innovative laboratory testing services for biomarker analyses and therapeutic evaluat( read more)..... |
|
| Press Release
2009-03-18 00:00:00.0
FDA has approved two new tests, developed by Bedford, Mass.-based Hologic, to screen for high-risk human papillomavirus types, the Boston Herald reports. Currently, there is only one FDA-approved test for HPV on the market, the Herald reports. Certain strains of HPV are a precursor to cervical cancer (McConville, Boston Herald, 3/14). According to U.S. News & World Report's "On Women," about 80% of women become infected with the sexually transmitted virus at some point in their lives, but in most cases, the virus clears on its own without causing problems (Kotz, U.S. News & World Report's "On Women," 3/17). According to Michael Gold, an associate professor at Vanderbilt University's gynecologic oncology division who reviewed data on the pro( read more)..... |
|
| Press Release
2009-03-17 00:00:00.0
HERZLIYA PITUACH, Israel - (BUSINESS WIRE) - CorAssist Cardiovascular Ltd., a developer of novel therapeutic devices for Diastolic Heart Failure (DHF), announced today that it has raised $5.25 million in a private financing led by Aurum Ventures MKI. The round was joined by previous investors Ofer Hi-Tech Group, Yozma Management, Evergreen Venture Partners and Argonaut Ventures.
"We have made significant progress with the ImCardiaT, as well as with our minimally invasive devices, the ImCardia-MIS and the CORrolla," said Amir Loshakove, CEO of CorAssist. "This additional capital enables us to continue the execution of our strategy of leadership in therapeutic devices for DHF."
The ImCardiaT is an elastic device placed on the outer su( read more)..... |
|
| Press Release
2009-03-10 00:00:00.0
The U.S. Food and Drug Administration today unveiled a new collaboration initiative with the Houston-based Alliance for NanoHealth (ANH) and its eight member institutions to help speed development of safe and effective medical products in the emerging field of nanotechnology.
Under a Memorandum of Understanding, the FDA/ANH Nanotechnology Initiative will work to expand knowledge of how nanoparticles behave and affect biologic systems, and to facilitate the development of tests and processes that might mitigate the risks associated with nanoengineered products. All outcomes from this public-private partnership will be placed in the public domain for the benefit of all stakeholders
"FDA's Nanotechnology Initiative with the Alliance for ( read more)..... |
|
| Press Release
2009-03-06 00:00:00.0
The U.S. Food and Drug Administration today announced its approval of a device that reduces the severity of adhesions in children undergoing open-heart surgery.
Repel-CV is a synthetic film barrier inserted over the heart just before a surgeon closes the chest following an open-heart procedure. During the early healing stages, the temporary, absorbable barrier helps reduce the severity of post-surgical adhesions.
Adhesions are bands of scar tissue that develop after surgery, infection, or other trauma. The bands can develop in any part of the body but are most commonly found in the abdomen, pelvis, or chest. Cardiac adhesions bind the outer membrane of the heart to surrounding tissue, which may restrict heart activity and complicate a( read more)..... |
|
| Press Release
2008-09-17 00:00:00.0
RAPS Honors Walker, Michor, Hoffman and Matsumoto
For Outstanding Contributions to Healthcare Product Regulatory Profession.
Global Leadership Award
Introduced last year, the Global Leadership Award recognizes professionals who exemplify leadership
and contributions toward worldwide development of the regulatory profession and RAPS.
This year's recipient, Salma Michor, PhD, RAC, is an independent consultant to the pharmaceutical
and medical device sectors, specializing in regulatory affairs, regulatory compliance, Quality Assurance, risk management and interim management. She also acts as a European Authorised
Representative. Previously, she worked for Chiesi-Torrex, Wyeth Whitehall and, most recently,
Croma Pharma, where she was ( read more)..... |
|
|
|
|
Press Release
2009-12-25 00:00:00.0
WASHINGTON, D.C. (Friday, December 25, 2009) - Biotechnology Industry Organ...
Press Release
2009-10-12 00:00:00.0
Research Triangle Park, NC and Tampa, FL (21 September 2009) - Magellan Bio...
Press Release
2009-05-26 00:00:00.0
Oak Park, IL, May 18, 2009 - PreLabs, LLC, a Chicago-based contract researc...
Press Release
2009-04-08 00:00:00.0
Oak Park, IL, October 1, 2008 - Biologic Safety Research Inc. (BSR) announc...
Press Release
2009-03-19 00:00:00.0
GeneuityT Clinical Research Services is exhibiting at the 18th Annual Partn...
Press Release
2009-03-18 00:00:00.0
FDA has approved two new tests, developed by Bedford, Mass.-based Hologic, ...
Press Release
2009-03-17 00:00:00.0
HERZLIYA PITUACH, Israel - (BUSINESS WIRE) - CorAssist Cardiovascular Ltd...
Press Release
2009-03-10 00:00:00.0
The U.S. Food and Drug Administration today unveiled a new collaboration in...
Press Release
2009-03-06 00:00:00.0
The U.S. Food and Drug Administration today announced its approval of a dev...
Press Release
2008-09-17 00:00:00.0
RAPS Honors Walker, Michor, Hoffman and Matsumoto
For Outstanding Contribu...
Press Release
2008-07-31 00:00:00.0
Colton Smith, PhD, was named special projects software developer for Geneui...
Press Release
2008-07-16 00:00:00.0
On July 8 and 9, Geneuity Clinical Research Services underwent an audit by ...
Press Release
2008-06-08 00:00:00.0
ContractLaboratory.com - The Laboratory Outsource Network! is pleased to an...
Press Release
2008-05-02 00:00:00.0
Aliso Viejo, Calif - Ambry Genetics is pleased to announce the acquisition ...
Press Release
2008-04-28 00:00:00.0
Geneuity Clinical Research Services was presented with a first-place honor ...
Press Release
2008-04-24 00:00:00.0
MARYVILLE, Tenn.-- (BUSINESS WIRE) -- Molecular Pathology Laboratory Networ...
Press Release
2008-04-21 00:00:00.0
MARYVILLE, Tenn.--(BUSINESS WIRE)--Molecular Pathology Laboratory Network (...
Press Release
2008-02-26 00:00:00.0
ContractLaboratory.com - The Laboratory Outsource Network! is pleased to an...
Press Release
2008-02-20 00:00:00.0
Geneuity Clinical Research Services will support the clinical trials indust...
Press Release
2008-02-13 00:00:00.0
ContractLaboratory.com - The Laboratory Outsource Network! is pleased to an...
|
|
|